Skip to menu Skip to content Skip to footer
Dr Sam Hollingworth
Dr

Sam Hollingworth

Email: 

Overview

Background

I am an academic and consultant working in global health with a focus on health technology assessment (HTA), health systems and services research, and the use of medicines in populations. I have a particular interest in the use of data and research for evidence-informed decision making and implementation science in the context of low and middle income countries, especially in sub-Saharan Africa. I have worked on international health projects in Indonesia and am currently working on several projects in HTA and medicines use in Ghana and sub-Saharan Africa. I work with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in general practice, cancer, psychiatry, neurology, and internal medicine. I have honorary or visiting appointments at the University of Queensland (UQ, Brisbane, Australia), Imperial College London (UK, International Decision Support Initiative) and Kwame Nkrumah University of Science and Technology (KNUST, Kumasi, Ghana). I have a BSc(Hons) and MPH from UQ and a PhD from Monash University. I have lived or worked in Australia (Brisbane, Melbourne), Canada (Toronto), Indonesia (Yogyakarta), UK (London), and Ghana (Accra, Kumasi). I worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). I am an experienced teacher having coordinated courses, lectured, and tutored in undergraduate and postgraduate programs. I was a Foundation Coordinator in the UQ Master of Pharmaceutical Industry Practice (from 2019). I am an advisor on diverse PhD and student research projects.

Availability

Dr Sam Hollingworth is:
Not available for supervision
Media expert

Qualifications

  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, Monash University
  • Masters (Coursework) of Public Health, The University of Queensland

Research interests

  • Health technology assessment (HTA) and decision-making

    Working with partners in low and middle income countries to manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably

  • Economic evaluations within health care and evidence-based practice

    Critically appraising the quality of evidence and ‘value for money’ of medicines and health services

  • Use of medicines in populations (pharmacoepidemiology)

    Exploring the use of medicines and their side effects using routinely collected data and describing the ‘real world’ effectiveness of medicines (e.g. in cancer)

  • Health systems, services, and medicines in non-communicable diseases

    Describing the use of medicines and other health services to treat non-communicable diseases (NCDs) with a focus on low and middle income countries

Works

Search Professor Sam Hollingworth’s works on UQ eSpace

212 works between 1988 and 2024

121 - 140 of 212 works

2016

Journal Article

Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study

Kay, Margaret, Wijayanayaka, Shanika, Cook, Harriet and Hollingworth, Samantha (2016). Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study. British Journal of General Practice, 66 (647), E397-E409. doi: 10.3399/bjgp16X685249

Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study

2016

Journal Article

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

Mayfield, Karla, Siskind, Dan, Winckel, Karl, Russell, Anthony W., Kisely, Steve, Smith, Greg and Hollingworth, Samantha (2016). Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes. Journal of Psychopharmacology, 30 (3), 227-236. doi: 10.1177/0269881115625496

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

2016

Conference Publication

Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme

McGrath, Alexandria, Sandhu, Geeta, McCaffrey, Elizabeth, Walpole, Euan, McKavanagh, Daniel and Hollingworth, Samantha (2016). Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15–17 November 2016. United Kingdom: Wiley-Blackwell . doi: 10.1111/ajco.12646

Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme

2016

Conference Publication

Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison

Kairuz, Therese, Truter, Ilse, Pudmenzky, Alex, Fredericks, Ian, Rossato, Laurence and Hollingworth, Samantha (2016). Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison. 2nd Medicines Utilisation Research in Africa Symposium, Gaborone, Botswana, 25-27 July 2016.

Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison

2016

Conference Publication

Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014

Ellen, Donges, Christine, Staatz, Paul, Kubler, Helen, Benham and Samantha, Hollingworth (2016). Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014. *, *, *. HOBOKEN: WILEY-BLACKWELL.

Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014

2016

Journal Article

A review of medication use as an indicator of human health impact in environmentally stressed areas

Hollingworth, Samantha A., Kim, Diane Dabok and Jagals, Paul (2016). A review of medication use as an indicator of human health impact in environmentally stressed areas. Annals of Global Health, 82 (1), 111-118. doi: 10.1016/j.aogh.2016.01.010

A review of medication use as an indicator of human health impact in environmentally stressed areas

2016

Conference Publication

Does consumer medicines interest reflect medicines use?

McGuire, T. M., Pache, D. M., van Driel, M. L. and Hollingworth, S. A. (2016). Does consumer medicines interest reflect medicines use?. Annual Conference of Australasian Pharmaceutical Science Association, Sydney University, Sydney, NSW, 2-5 December 2016.

Does consumer medicines interest reflect medicines use?

2015

Journal Article

Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy

Fredericks, Ian, Hollingworth, Samantha, Pudmenzky, Alex, Rossato, Laurence, Syed, Shahzad and Kairuz, Therese (2015). Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy. International Journal of Clinical Pharmacy, 37 (6), 1213-1221. doi: 10.1007/s11096-015-0188-y

Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy

2015

Conference Publication

Lenalidomide Use in Relapsed or Refractory Multiple Myeloma Patients At Five Large Queensland Public Hospitals

McKavanagh, Daniel, Walpole, Euan, Hollingworth, Samantha, Sharkey, Megan and Mollee, Peter (2015). Lenalidomide Use in Relapsed or Refractory Multiple Myeloma Patients At Five Large Queensland Public Hospitals. HOBOKEN: WILEY-BLACKWELL.

Lenalidomide Use in Relapsed or Refractory Multiple Myeloma Patients At Five Large Queensland Public Hospitals

2015

Journal Article

Dopamine agonists: time pattern of adverse effects reporting in Australia

Hollingworth, Samantha A., McGuire, Treasure M., Pache, David and Eadie, Mervyn J. (2015). Dopamine agonists: time pattern of adverse effects reporting in Australia. Drugs - Real World Outcomes, 2 (3), 199-203. doi: 10.1007/s40801-015-0028-3

Dopamine agonists: time pattern of adverse effects reporting in Australia

2015

Journal Article

Opioid analgesic prescribing in Australia: a focus on gender and age

Hollingworth, Samantha A., Gray, Paul D., Hall, Wayne D. and Najman, Jake M. (2015). Opioid analgesic prescribing in Australia: a focus on gender and age. Pharmacoepidemiology and Drug Safety, 24 (6), 628-636. doi: 10.1002/pds.3767

Opioid analgesic prescribing in Australia: a focus on gender and age

2015

Journal Article

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

Forrester, T., Siskind, D., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013. Pharmacopsychiatry, 48 (4-5), 164-169. doi: 10.1055/s-0035-1554713

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

2015

Journal Article

Clozapine-induced myocarditis: separating the wheat from the chaff

Winckel, Karl, Siskind, Dan, Hollingworth, Samantha and Wheeler, Amanda (2015). Clozapine-induced myocarditis: separating the wheat from the chaff. Australian and New Zealand Journal of Psychiatry, 49 (2), 188-188. doi: 10.1177/0004867414554269

Clozapine-induced myocarditis: separating the wheat from the chaff

2015

Journal Article

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

Mayfield, Karla, Siskind, Dan, Winckel, Karl, Hollingworth, Samantha, Kisely, Steve and Russell, Anthony W. (2015). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial. BJPsych Open, 1 (1), 67-73. doi: 10.1192/bjpo.bp.115.001073

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

2015

Conference Publication

Reported Clozapine-Related Adverse Drug Reactions in Australia 1993-2013

Siskind, D., Kolomensky, A., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Reported Clozapine-Related Adverse Drug Reactions in Australia 1993-2013. RANZCP 2015 Congress, Brisbane, QLD Australia, 3-7 May 2015. London, United Kingdom: Sage Publications. doi: 10.1177/0004867415578344

Reported Clozapine-Related Adverse Drug Reactions in Australia 1993-2013

2015

Journal Article

Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal

Khanal, Saval, Veerman, Lennert, Hollingworth, Samantha and Nissen, Lisa (2015). Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal. Perspective in Public Health, 135 (4), 177-178. doi: 10.1177/1757913915586654

Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal

2015

Conference Publication

Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.

Donges, E., Staatz, C. E. and Hollingworth, S. A. (2015). Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.. APSA-ASCEPT conference, Hobart, Australia, 29th November - 2nd December 2015.

Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.

2015

Journal Article

Clozapine in the community: improved access or risky free- for-all

Winckel, Karl, Siskind, Dan, Hollingworth, Sam, Robinson, Gail, Mitchell, Scott, Varghese, Daniel, Smith, Lesley and Wheeler, Amanda (2015). Clozapine in the community: improved access or risky free- for-all. Australian and New Zealand Journal of Psychiatry, 49 (10), 863-865. doi: 10.1177/0004867415592957

Clozapine in the community: improved access or risky free- for-all

2014

Journal Article

Multiple sclerosis disease modifying medicine utilisation in Australia

Hollingworth, Samantha, Walker, Kimitra, Page, Andrew and Eadie, Mervyn (2014). Multiple sclerosis disease modifying medicine utilisation in Australia. Journal of Clinical Neuroscience, 21 (12), 2083-2087. doi: 10.1016/j.jocn.2014.05.034

Multiple sclerosis disease modifying medicine utilisation in Australia

2014

Conference Publication

Shaping the future of clozapine: safety implications of increased use

Hollingworth, S., Forrester, V., Winckel, K., Wheeler, A. and Siskind, D. (2014). Shaping the future of clozapine: safety implications of increased use. National Medicines Symposium 2014, Brisbane, QLD Australia, 21 - 23 May 2014.

Shaping the future of clozapine: safety implications of increased use

Funding

Past funding

  • 2021 - 2024
    Opioids and other prescription medicines use in people presenting to Queensland emergency departments for acute minor (non-admitted) Road Traffic Crash injury: a one year community follow-up study usi
    Metro South Hospital and Health Service
    Open grant
  • 2013 - 2014
    Utilisation review of Ezetimibe
    Department of Health and Ageing
    Open grant
  • 2012 - 2013
    Prescription opioid users in Australia- just who are they?
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010 - 2018
    NHMRC CRE: Improving quality and safety of health care delivery at the interface between primary and acute care sectors
    NHMRC Centres of Research Excellence
    Open grant

Supervision

Availability

Dr Sam Hollingworth is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Dr Sam Hollingworth directly for media enquiries about:

  • health services research
  • medicine use in populations
  • pharmacoepidemiology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au